Variant Summary
- HGVS
- —
- Variant Type(s)
- —
- Evidence Items
- 7
Evidence Level Distribution
Level B: 5Level D: 2
Evidence Items
Showing CIViC evidence rows where gene = TP53 and variant = Deleterious Mutation.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| B | Prognostic | Does Not Support | Poor Outcome | Lung Non-small Cell Carcinoma | 4 | |
| D | Predictive | Supports | Resistance | Cancer | MDM2 Inhibitor AMGMDS3 | 4 |
| D | Predictive | Supports | Resistance | Cancer | Rebemadlin | 4 |
| B | Predictive | Supports | Resistance | Leukemia | RG7112 | 3 |
| B | Prognostic | Supports | Poor Outcome | Head And Neck Squamous Cell Carcinoma | 3 | |
| B | Predictive | Does Not Support | Sensitivity/Response | Lung Non-small Cell Carcinoma | Adjuvant Chemotherapy | 2 |
| B | Predictive | Supports | Sensitivity/Response | Sarcoma | Pazopanib | 2 |